Bio

ABOUT AARON NEINSTEIN, MD

 

Dr. Aaron Neinstein is Associate Professor in the UCSF Division of Endocrinology and Director of Clinical Informatics at the UCSF Center for Digital Health Innovation, with a clinical practice focused on diabetes care. He is considered an expert in diabetes technology, including the use of insulin pumps and continuous glucose monitors, as a nationally-invited speaker and invited author to outlets like CNBC and Medscape, peer-reviewed author, and advisor to numerous companies. He was named by Marin Magazine to the Bay Area [415] Top Doctors List in 2020. In his clinical practice, he takes care of patients with diabetes as well as with disorders of the thyroid, adrenal, pituitary, ovaries, and testes, or other metabolic issues. (Note: If you are looking for a second opinion for an endocrine issue and are unable to come to UCSF, Dr. Neinstein can provide you a second opinion via UCSF’s online second opinion service.)

Dr. Neinstein is board certified in Endocrinology, Internal Medicine, and Clinical Informatics.  He was an inaugural inductee as a Fellow of the American Medical Informatics Association, and has focused his career on empowering patients and physicians to better access, share, understand, and use health information for more connected, collaborative care. He helped lead the Epic EHR implementation at UCSF and was on the founding team of Tidepool, a non-profit that creates open-source software to empower people with diabetes. At the UCSF CDHI, he leads a multi-disciplinary team focused on advancing interoperability and digital transformation of care delivery, including the use of telehealth and remote monitoring technologies to advance more connected care.

About This Blog

This blog (as detailed in my first blog post in Feb 2012), was originally launched with a focus specifically on innovations in diabetes and diabetes technology. Since 2000, when I first decided to become a physician, diabetes has been an integral part of my career. I re-named the blog after a few years to reflect the fact that lessons learned in redesigning diabetes care are applicable across healthcare.

In addition to this blog, I also write a regular column at Medscape.com, “Aaron Neinstein on Digital Health.”

Thanks for reading and for participating!

Aaron Neinstein, MD

(last updated Apr 2017)

Disclosures

Research Grants

  • Cisco Systems Inc (2016)
  • Commonwealth Fund (2018-2019)

Speaking Honoraria

  • UCSF CME
  • Academy Health (2018)
  • Symposia Medicus (2017)

Other

  • Maslon LLP
  • Elite Medical Experts

Consultant / Advisory Board (With Financial Compensation)

  • Intuity Medical (2020-present)
  • Medtronic (2020-present)
  • Roche (2020-present)
  • Eli Lilly (2020-present)
  • Steady Health (2018-present)
  • HealthQuest Capital (2018)
  • Nokia Growth Partners (2017-2018)
  • WebMD/Medscape (2015-present)
  • Grand Rounds (2014)
  • GLG (2014-present)

Consultant / Advisory Board (Without Financial Compensation)

  • Tidepool (2012-present)

Selected Invited Speeches and Panels

Disclosures

Research Grants

  • Cisco Systems Inc (2016)
  • Commonwealth Fund (2018-2019)

Speaking Honoraria

  • UCSF CME
  • Academy Health (2018)
  • Symposia Medicus (2017)

Consultant / Advisory Board (With Financial Compensation)

  • Steady Health (2018-present)
  • HealthQuest Capital (2018)
  • Nokia Growth Partners (2017-2018)
  • WebMD/Medscape (2015-present)
  • Grand Rounds (2014)
  • GLG (2014-present)

Consultant / Advisory Board (Without Financial Compensation)

  • Tidepool (2012-present)

Other

  • Maslon LLP
  • Elite Medical Experts